MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horenstein, J.
Right arrow Articles by Akabas, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horenstein, J.
Right arrow Articles by Akabas, M. H.

Vol. 53, Issue 5, 870-877, May 1998

Location of a High Affinity Zn2+ Binding Site in the Channel of alpha 1beta 1 gamma -Aminobutyric AcidA Receptors

Jeffrey Horenstein and Myles H. Akabas

Center for Molecular Recognition (J.H., M.H.A.) and the Departments of Physiology and Cellular Biophysics (J.H., M.H.A.) and Medicine (M.H.A.), Columbia University, New York, New York 10032

    Summary
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Zn2+ inhibits currents through gamma -aminobutyric acid (GABA)A receptors. Its affinity depends on the subunit composition; alpha 1beta 1 receptors are inhibited with high affinity (IC50 = 0.54 µM). We sought to identify the residues that form this high affinity Zn2+ binding site. beta 1His267 aligns with alpha 1Ser272, a residue near the extracellular end of the M2 membrane-spanning segment that we previously demonstrated to be exposed in the channel. The Zn2+ affinity of alpha 1beta 1 H267S was reduced by 300-fold (IC50 = 161 µM). Addition of a histidine at the aligned position in alpha 1 creates a receptor, alpha 1S272Hbeta 1, that should have five channel-lining histidines; the Zn2+ affinity was increased 20-fold (IC50 = 0.025 µM). Shifting the position of the histidine from the beta 1 subunit to the aligned position in alpha 1 with the two mutants alpha 1S272Hbeta 1H267S reduced the affinity (IC50 = 26 µM) compared with wild-type. We infer that the high affinity Zn2+ binding site involves beta 1His267 from at least two subunits. For two histidines to interact with a Zn2+ ion, the alpha  carbons must be separated by <13 Å. This limits the separation of the subunits and provides a constraint on the possible quaternary structures of the channel. The ability of a divalent cation to penetrate from the extracellular end of the channel to beta 1His267 implies that the charge-selectivity filter, the structure that discriminates between anions and cations, is located at a more cytoplasmic position than beta 1His267; this is consistent with our previous work that showed that positively charged sulfhydryl-specific reagents reacted with an engineered cysteine residue as cytoplasmic as alpha 1T261C.

    Introduction
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

The GABAA receptors are members of the ligand-gated ion channel gene superfamily and form anion-selective channels (Macdonald and Olsen, 1994; Karlin and Akabas, 1995; Sieghart, 1995). The functional receptor complex is formed as a pentamer of homologous subunits arranged pseudosymmetrically around the central channel axis (Unwin, 1993; Macdonald and Olsen, 1994; Nayeem et al., 1994). Numerous GABAA receptor subunits have been cloned, including six alpha , four beta , three gamma , one delta , one epsilon , and three rho  subunits (Macdonald and Olsen, 1994; Sieghart, 1995). The subunits have a similar transmembrane topology with an ~200-amino acid extracellular amino terminus, three closely spaced membrane-spanning segments (M1, M2, M3), a cytoplasmic loop of variable length, a fourth membrane-spanning segment (M4), and an extracellular carboxyl terminus (Macdonald and Olsen, 1994). Using the substituted-cysteine-accessibility method, we have shown that the channel lining is formed, at least in part, by residues from the M2 segment (Xu and Akabas, 1996).

Functional receptors are formed by coexpression of alpha  and beta  subunits, although the presence of the gamma  subunit is essential for benzodiazepine potentiation (Schofield et al., 1987; Pritchett et al., 1989; Gorrie et al., 1997). In heterologous expression systems, the subunit stoichiometry for receptors formed by expression of the alpha  and beta  subunits is uncertain; support has been provided for two alpha  and three beta  subunits (Tretter et al., 1997) and for three alpha  and two beta  subunits (Im et al., 1995; Kellenberger et al., 1996), as well as other stoichiometries (Gorrie et al., 1997). When the gamma  subunit is included, the stoichiometry seems to be two alpha , two beta , and one gamma  subunit (Chang et al., 1996; McKernan and Whiting, 1996; Tretter et al., 1997). Some beta  subunits also form homomeric channels, but they tend to be constitutively open (Krishek et al., 1996).

The divalent cation Zn2+ blocks GABA-induced currents with variable affinity depending on the subunit composition of the receptors (Westbrook and Mayer, 1987; Draguhn et al., 1990; Legendre and Westbrook, 1991; Smart et al., 1991; Harrison and Gibbons, 1994; Saxena and Macdonald, 1994; Smart et al., 1994; Chang et al., 1995; Wang et al., 1995). It is likely that the effects of Zn2+ are mediated by interactions with different sites in receptors with different subunit compositions (Harrison and Gibbons, 1994; Smart et al., 1994; Saxena et al., 1997). Receptors formed by coexpression of alpha  and beta  subunits display the highest affinity for Zn2+ block with an IC50 of ~1 µM (Draguhn et al., 1990; Smart et al., 1991). In these receptors, Zn2+ block is slightly voltage dependent (Draguhn et al., 1990), implying that the binding site may be in the channel. The beta  homomeric channels also display high affinity Zn2+ block (Draguhn et al., 1990; Krishek et al., 1996). The addition of the gamma 2 subunit to the functional complex markedly reduced Zn2+ block so that 100 µM Zn2+ caused only 17% inhibition of the GABA-induced currents (Draguhn et al., 1990; Smart et al., 1991). Zn2+ has been proposed to inhibit GABA-induced currents by stabilizing the closed state of the receptor (Smart et al., 1994). We sought to identify the residues that form the high affinity Zn2+ binding site in the alpha 1beta 1 GABAA receptor.

In proteins of known crystal structure, bound Zn2+ ions interact directly with two to four amino acids. The amino acids found at Zn2+ binding sites include histidine, cysteine, aspartate, or glutamate (Higaki et al., 1992; Regan, 1993; Berg and Shi, 1996). Because charged, water-soluble, sulfhydryl reactive reagents applied extracellularly have no effect on GABAA receptors (Xu and Akabas, 1993, 1996) it is unlikely that a cysteine residue is available to interact with extracellularly applied Zn2+. In GABA receptors formed by the rho 1 subunit, a histidine residue in the extracellular domain was shown to mediate lower affinity Zn2+ block (IC50 = 16 µM) (Wang et al., 1995); histidine, however, is not conserved at the aligned position in other subunits. In the aligned sequences of GABAA receptor subunits, we noted that histidine was conserved at the position aligned with beta 1His267 in all beta  subunits but is not found at the aligned position in other subunit subtypes. This position aligns with alpha 1Ser272 in the M2 membrane-spanning segment; we had previously shown that this residue was exposed in the channel lining (Fig. 1) (Xu and Akabas, 1996). We hypothesized that the high affinity Zn2+ binding site was formed by histidine residues from position beta 1 267 contributed by at least two beta  subunits.


View larger version (11K):
[in this window]
[in a new window]
 
Fig. 1.   Aligned sequences in and flanking the M2 membrane-spanning segments of the rat GABAA receptor alpha 1, beta 1, and gamma 2 subunits. Shaded, residues aligned with beta 1His267; *, channel-lining residues identified in the alpha 1 subunit by Xu and Akabas (1996).

    Materials and Methods
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Oligonucleotide-mediated mutagenesis. The cDNAs encoding the rat alpha 1 and gamma 2 subunits in the pBluescript SK(-) plasmid (Stratagene, La Jolla, CA) were obtained from Dr. P. Seeburg (Max-Planck Institute for Medical Research, Heidelberg, Germany), and the beta 1 subunit in the pBluescript SK vector was from Dr. A. Tobin (University of California, Los Angeles). The subunits were excised from the pBluescript clones by restriction digestion with the enzymes alpha 1 XhoI, beta 1 XbaI and HindIII, and gamma 2 EcoRI. The beta 1 and gamma 2 subunits were ligated into the pGEMHE vector (Liman et al., 1992) digested with the corresponding enzymes. For the alpha 1 subunit, the XhoI cut fragment was blunt ended and ligated into pGEMHE, which had been digested with SmaI. Subcloning and orientation were confirmed by restriction digestion and DNA sequencing. The Altered-Sites Mutagenesis procedure (Promega, Madison, WI) was used to generate mutations as described previously (Xu et al., 1995). Mutations were confirmed by DNA sequencing.

Preparation of mRNA and oocytes. Plasmids were linearized with NheI for in vitro mRNA transcription with T7 RNA polymerase. In vitro mRNA transcription and the preparation and injection of Xenopus laevis oocytes were performed as described previously (Xu et al., 1995). Oocytes were injected with 10 ng of mRNA encoding the alpha 1 and beta 1 subunits in a 1:1 ratio or with alpha 1, beta 1, and gamma 2 subunits in a 1:1:1 ratio.

Electrophysiology. GABA-induced currents were recorded from individual oocytes under two-electrode voltage-clamp, at a holding potential of -50 mV. Electrodes were filled with 3 M KCl and had a resistance of <2 MOmega . The ground electrode was connected to the bath via a 3 M KCl/Agar bridge. Data were acquired and analyzed on a 486/33 MHz computer using a TEV-200 amplifier (Dagan Instruments, Minneapolis, MN), a Digidata 1200 data interface (Axon Instruments), and pCLAMP 6 software (Axon Instruments, Foster City, CA). The oocyte was perfused at 5 ml/min with CFFR (115 mM NaCl, 2.5 mM KCl, 1.8 mM MgCl2, 10 mM HEPES, pH 7.5, with NaOH) at room temperature. The recording chamber had a volume of ~0.25 ml.

Experimental protocol. In all experiments, GABA was applied at a concentration 10 times the GABA EC50 value of the mutant or wild-type unless otherwise indicated. Applications of GABA were separated by 3-5-min washes with CFFR. In all experiments used for analysis, the magnitude of the GABA-induced current changed by <10% between two consecutive applications of GABA.

To determine the Zn2+ IC50 value, an increasing series of Zn2+ concentrations were applied. Each concentration of ZnCl2 was applied according to the following protocol: ZnCl2 in CFFR, 1 min; ZnCl2 plus GABA in CFFR, 20 sec; ZnCl2 in CFFR, 30 sec; CFFR, 5 min.

The experiments to determine the effects of the sulfhydryl reagents on the beta 1H267C mutant were performed as described previously (Xu and Akabas, 1996). The sequence of reagents applied was GABA, 20 sec; GABA, 20 sec; sulfhydryl reagent, 1 min; GABA, 20 sec; GABA, 20 sec. For a given oocyte, the concentration of GABA used was either the GABA EC50 or 10 times the EC50 value of the receptor (see Table 1 for EC50 values). The fractional effect was taken as [(IGABA, after/IGABA, before- 1]. The sulfhydryl reagents were dissolved in CFFR immediately before application.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1
GABA EC50 values

Curve fitting. The concentration dependence of the inhibition of the GABA-induced currents by Zn2+ was fit with the Hill equation, I/Imax = 1/[1 + (IC50/Zn)n], where IC50 is the concentration of Zn2+ that causes half-maximal inhibition, Zn is the concentration of Zn2+, and n is the Hill coefficient, using either Prism 2.0 (GraphPAD, San Diego, CA) or custom software kindly provided by Dr. Juan Pascual (Columbia University, New York, NY).

Reagents. A 1 M stock solution of ZnCl2 was prepared by adding sufficient HCl to eliminate all visible precipitates. All working solutions of ZnCl2 were prepared daily by diluting the 1 M stock solution in CFFR. The addition of ZnCl2 to CFFR did not change the pH of the solution.

The MTS derivatives MTSES-, MTSET+, and MTS ethylammonium were synthesized as described previously (Stauffer and Karlin, 1994) or obtained commercially (Toronto Research Chemicals, North York, Ontario, Canada). These reagents react with cysteine and add ---SCH2CH2X, the charged portion of the molecule onto the sulfhydryl; where X is SO3- for MTSES-, NH3+ for MTS ethylammonium, and N(CH3)3+ for MTSET+. The organic mercurial pCMBS- was obtained from Sigma Chemical (St. Louis, MO). It adds HgC6H4SO3- onto the cysteine.

    Results
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Characterization of the mutants. We expressed all of the mutants in X. laevis oocytes as either alpha 1beta 1 or alpha 1beta 1gamma 2 combinations where the mutant subunit or subunits replaced the corresponding wild-type subunit or subunits. GABA-induced currents were observed in oocytes expressing each of the combinations. For all of the subunit combination, we determined the EC50 value for GABA and the Hill coefficient of the GABA dose-response relationship (Table 1). For wild-type alpha 1beta 1, the GABA EC50 value was 3.4 ± 0.7 µM and the Hill coefficient was 0.97 ± 0.12. The EC50 values of the mutants ranged from 5-fold smaller than wild-type for alpha 1beta 1H267S to 1.6-fold larger than wild-type for the alpha 1S272Hbeta 1 mutant. The EC50 value is a function of both the intrinsic affinity of the binding sites for GABA and the isomerization rate constants for transitions between the various closed, open, and desensitized states (Akabas et al., 1992). Because channel gating involves conformational changes in the membrane-spanning segments to transduce ligand binding in the extracellular domain to opening of the gate near the cytoplasmic end of the channel (Xu and Akabas, 1996), mutations of residues in membrane-spanning segments can alter the isomerization rate constants. Thus, the observed changes in EC50 probably arise from effects of the mutations on the transduction process.

Residues forming the high affinity Zn2+ binding site. Zn2+ blocked GABA-induced currents arising from wild-type alpha 1beta 1 GABAA receptors with an IC50 value of 0.54 ± 0.02 µM (four experiments) (Fig. 2) similar to the IC50 values reported by other investigators for alpha xbeta y receptors (Draguhn et al., 1990; Smart et al., 1991). beta 1His267 aligns with alpha 1Ser272, a residue that we had previously shown to be a channel-lining residue (Xu and Akabas, 1996). To determine whether beta 1His267 was involved in forming the high affinity Zn2+ binding site, we mutated the histidine to the amino acids found at the aligned positions in the alpha 1 and gamma 2 subunits, serine and isoleucine, respectively (Fig. 1). The affinity for Zn2+ block of both mutants was reduced by >300-fold (Fig. 2); for alpha 1beta 1H267S, the IC50 value was 161 ± 40 µM (three experiments), and for alpha 1beta 1H267I, the IC50 value was 654 ± 113 µM (nine experiments) (Table 2). The residual inhibition likely arises from an interaction of Zn2+ with a different site or sites on the receptor; removal of the high affinity site has unmasked this previously unrecognized low affinity site or sites. The location of this low affinity binding site is unknown.


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   High affinity Zn2+ inhibition of wild-type alpha 1beta 1 GABAA receptors is reduced in the mutants alpha 1beta 1H267S and alpha 1beta 1H267I. A, GABA-induced currents recorded by two-electrode voltage clamp from an oocyte expressing wild-type alpha 1beta 1 receptors in the presence of varying concentrations of ZnCl2. B, Concentration dependence of the Zn2+ inhibition of GABA-induced currents for wild-type alpha 1beta 1 (open circle ), alpha 1beta 1H267S (black-triangle), and alpha 1beta 1H267I (black-down-triangle ). Mean ± standard error values are plotted; for some points, the error bars are smaller than the symbol. The data were fit by the Hill equation. Solid lines, calculated from the fitted equation.

                              
View this table:
[in this window]
[in a new window]
 
TABLE 2
Zn2+ IC50 values

Interactions with residues in other subunits. To investigate whether a histidine at the aligned position in the alpha 1 subunit would interact with beta 1His267, we generated the mutant alpha 1S272H and expressed it with the wild-type beta 1 subunit. With five histidines in the channel lining, the IC50 value of the alpha 1S272Hbeta 1 receptor was 0.025 ± 0.007 µM (three experiments) (Fig. 3); that the affinity was significantly higher than wild-type suggests that the aligned residues in different subunits are in close proximity in the channel lumen. To ensure that the higher affinity was not solely due to placement of the histidine in the alpha 1 subunit, we examined the effect of Zn2+ on the receptor that at this position only contained histidine in the alpha 1 subunit, alpha 1S272Hbeta 1H267S; the IC50 value was 26 ± 1 µM (eight experiments) (Fig. 3, Table 2). The affinity of alpha 1S272Hbeta 1H267S for Zn2+ was lower than that in wild-type but higher than that in the alpha 1beta 1H267S receptor, a receptor with no histidines at this level of the channel.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   The affinity for Zn2+ inhibition is increased in the alpha 1S272Hbeta 1 receptor and decreased in the alpha 1S272Hbeta 1H267S receptor relative to the wild-type alpha 1beta 1 receptor. Concentration dependence of the Zn2+ inhibition of GABA-induced currents for wild-type alpha 1beta 1 (open circle ), alpha 1S272Hbeta 1 (bullet ), and alpha 1S272Hbeta 1H267S (black-triangle). Mean ± standard error values are plotted; for some points, the error bars are smaller than the symbol. The data were fit by the Hill equation. Solid lines, calculated from the fitted equation.

Cysteine substitution for beta 1His267. It was hypothesized that Zn2+ inhibits GABA-induced currents by binding to and stabilizing the closed state of the GABAA receptor (Smart et al., 1994). Therefore, we sought to determine whether beta 1His267 was accessible to interact with ions in the closed state of the channel. We used the substituted-cysteine-accessibility method (Akabas et al., 1992; Xu and Akabas, 1993) to probe the accessibility of a cysteine residue substituted at position 267 in the closed state of the channel. In this approach, a cysteine residue is engineered into the protein. The cysteine-substitution mutant is expressed, and the ability of charged, sulfhydryl-specific reagents to react with the engineered cysteine residue is tested. The magnitude of the GABA-induced current is determined; then, the sulfhydryl reagent is applied for 1 min in the absence of GABA (i.e., in the closed state of the channel) and washed out, and the magnitude of the GABA-induced current is determined again. If the magnitude of the GABA-induced currents after application of the sulfhydryl reagent is significantly different than the magnitude of the GABA-induced currents before application of the sulfhydryl reagent, we infer that the sulfhydryl reagent has covalently modified the engineered cysteine. The sulfhydryl reagents we used are pCMBS-, MTSES-, and MTSET+ (Xu and Akabas, 1996). Because these reagents react more rapidly with the thiolate anion (S-) than with the neutral thiol (SH) (Hasinoff et al., 1971; Roberts et al., 1986) and because only cysteines on the water-accessible surface of the protein are likely to ionize to a significant extent, we assume that these reagents will only react with cysteine residues on the water-accessible surface of the protein at an appreciable rate. Covalent modification of a channel-lining cysteine may alter the single-channel conductance and/or the gating kinetics (Akabas et al., 1994). To detect the effects of covalent modification, we used two different test concentrations of GABA: one at the GABA EC50 value and the other at 10 times the EC50 value. Zhang and Karlin (1997) have shown that applying the agonist at the EC50 value for the test responses before and after the reagent provides a more sensitive test for detecting covalent modification because it allows one to detect reaction when the effect of modification is a change in gating alone with little or no change in single-channel conductance. In contrast, application at 10 times the EC50 value will detect changes in conduction but should be insensitive to changes in gating.

A 1-min application of 0.5 mM pCMBS-, 10 mM MTSES-, or 1 mM MTSET+ in the absence of GABA had no significant effect on wild-type alpha 1beta 1 GABAA receptors whether the test concentration of GABA was at the EC50 or 10 times the EC50 value (Fig. 4C, open bars). For the alpha 1beta 1H267C mutant, when the test concentration of GABA was 5 µM, the EC50 value for the mutant (Table 1), a 1-min application of 0.5 mM pCMBS-, 10 mM MTSES-, or 1 mM MTSET+ in the absence of GABA potentiated the subsequent GABA-induced currents by ~50% (Fig. 4, A and C, left). For the alpha 1beta 1H267C mutant, when the test concentration of GABA was 50 µM, 10 times the EC50 value for the mutant, a 1-min application of 1 mM MTSET+ caused a 31% potentiation of the subsequent GABA-induced currents but a 1-min application of 0.5 mM pCMBS- or 10 mM MTSES- had no significant effect on the subsequent GABA-induced currents (Fig. 4, B and C, right). Thus, in the closed state of the receptor, the engineered cysteine was accessible to react with all three of the reagents. Therefore, we infer that the corresponding wild-type residue, beta 1His267, is on the water-accessible surface of the protein in the closed state of the channel and therefore available to interact with Zn2+.


View larger version (19K):
[in this window]
[in a new window]
 
Fig. 4.   The engineered cysteine in the mutant alpha 1beta 1H267C is accessible to covalent modification by charged, sulfhydryl-specific reagents applied extracellularly in the closed state of the receptor. A and B, Currents recorded from oocytes expressing the mutant alpha 1beta 1H267C by two-electrode voltage-clamp. Bars over the traces, periods during which reagents were applied to the oocytes. Holding potential was -50 mV. Note the increase in the magnitude of the two current responses after the application of MTSET+ relative to the initial two responses. Traces, separated by a 5-min wash with CFFR. The GABA concentration was 5 µM in A and 50 µM in B. C, Effect of a 1-min application of 0.5 mM pCMBS-, 10 mM MTSES-, or 1 mM MTSET+ applied extracellularly in the absence of GABA on wild-type (square ) and alpha 1beta 1H267C (). The test concentrations of GABA were at the EC50 value (left) and at 10 times the EC50 value (right). Mean ± standard error values are plotted. Parentheses, number of oocytes tested. Positive effect, potentiation of the subsequent GABA-induced currents; negative effect, inhibition of the subsequent GABA-induced currents.

Based on the differences between the effects of modification as probed with GABA test concentrations at the EC50 and 10 times EC50 value, we infer that the cationic reagent MTSET+ alters conduction and probably also gating, but the major effect of modification by the anionic reagents pCMBS- and MTSES- is on gating. It was surprising that modification by all three reagents resulted in potentiation of the subsequent GABA-induced currents. Presumably, the presence of a charged residue, that is, the covalently modified cysteine, at this position stabilizes the open state; the mechanism, however, is unknown.

Cysteine residues are frequently involved in the formation of Zn2+ binding sites (Higaki et al., 1992; Regan, 1993; Berg and Shi, 1996); therefore, we tested the effect of Zn2+ on alpha 1beta 1H267C. Zn2+ inhibited the GABA-induced currents; the IC50 value was 23 ± 3 µM (five experiments) (Table 2). Although the affinity of alpha 1beta 1H267C for Zn2+ was 40-fold lower than wild-type, it was 7- and 28-fold higher than the corresponding serine and isoleucine mutants at this position. Thus, we believe that Zn2+ is binding to the engineered cysteine or cysteines. Furthermore, covalent modification of the engineered cysteine by either 10 mM MTSES- or 5 mM MTSET+ reduced the ability of Zn2+ to inhibit the alpha 1beta 1H267C. Before modification, Zn2+ inhibited alpha 1beta 1H267C with an IC50 of 23 ± 3 µM (five experiments) (Table 2); after modification of alpha 1beta 1H267C by either MTSES- or MTSET+, the IC50 value for Zn2+ inhibition of GABA-induced currents was >1 mM (three experiments) (Fig. 5). Thus, covalent modification of the cysteine prevents it from interacting with Zn2+.


View larger version (7K):
[in this window]
[in a new window]
 
Fig. 5.   Covalent modification of the engineered cysteine in the alpha 1beta 1H267C mutant reduces the inhibition by Zn2+. The reagents were applied during the periods indicated (bars above the traces) at 2 µM GABA, 5 mM MTSET+, and 30 µM Zn2+. Zn2+ inhibited the GABA-induced current by 63% before modification by MTSET+ and by 14% after modification by MTSET+. All other conditions were the same as for Fig. 4. Note that the rate of GABA-induced desensitization is increased after modification.

Effect of the gamma 2 subunit on Zn2+ affinity. It has previously been shown that the IC50 value for Zn2+ inhibition of GABAA receptors containing the gamma 2 subunit is much higher than that for receptors formed from only the alpha  and beta  subunits (Draguhn et al., 1990; Smart et al., 1991). Consistent with this, we found that the Zn2+ IC50 value for wild-type alpha 1beta 1gamma 2 was >1 mM (three experiments). In the gamma 2 subunit, the residue Ile282 aligns with beta 1His267 (Fig. 1). We mutated this residue to histidine, gamma 2I282H, and expressed the mutant with wild-type alpha 1 and beta 1 subunits, but the Zn2+ IC50 value also was >1 mM (three experiments) (Table 2). Expression of the other combinations of histidines at this position alpha 1S272Hbeta 1H267Sgamma 2I282H, and alpha 1S272Hbeta 1gamma 2I282H, which should contain five histidines, also gave IC50 values of >1 mM (Table 2). Thus, inclusion of the gamma 2 subunit prevents the ability of Zn2+ to inhibit GABA-induced currents regardless of the number of histidines present at this level.

    Discussion
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References

Zn2+ is a high affinity inhibitor of alpha 1beta 1 GABAA receptors (Draguhn et al., 1990; Smart et al., 1991). We have shown that the Zn2+ affinity of alpha 1beta 1 GABAA receptors is reduced by >300-fold by mutation of beta 1His267 in the M2 membrane-spanning segment to either serine or isoleucine, the amino acids at the aligned positions in the alpha 1 and gamma 2 subunits (Fig. 1). Furthermore, we have shown that beta 1His267 is exposed in the channel lining (Fig. 4) as we had previously shown for the aligned residue in the alpha 1 subunit, alpha 1Ser272 (Xu and Akabas, 1996). Histidine is conserved at the position aligned with beta 1His267 in all GABAA receptor beta  subunits but is not found at the aligned position in other subunit subtypes. Histidine residues frequently form part of metal ion binding sites (Higaki et al., 1992; Regan, 1993; Berg and Shi, 1996). Thus, we infer that beta 1His267 participates in the formation of the high affinity Zn2+ site in alpha 1beta 1 GABAA receptors. The position of this residue near the extracellular end of the M2 channel-lining segment is consistent with the slight voltage dependence reported for Zn2+ block of alpha 1beta 1 GABAA receptors (Draguhn et al., 1990). A different histidine in the extracellular amino-terminal domain of the GABA rho 1 subunit was implicated in lower affinity Zn2+ inhibition of the GABAC receptor (Wang et al., 1995).

Because the GABAA receptor is formed as a pentamer of subunits arranged pseudosymmetrically around the central channel axis (Unwin, 1993; Nayeem et al., 1994), one would hypothesize that the aligned channel-lining residues from each subunit should be at approximately the same distance into the channel, thereby forming a ring of residues at a given level of the channel. Insertion of histidine into the aligned position in the alpha 1 subunit and expression with wild-type beta 1, which should give five histidines at this level, increases the affinity for Zn2+ by 20-fold. This suggests that the aligned residues in different subunits are in close proximity in the channel lumen and that the presence of more histidines at this level allows for the formation of a higher affinity binding site.

To form a high affinity binding site, Zn2+ must interact with more than one residue. The affinity of a site will depend on the number of chelating residues, the relative position of the residues, and the local electrostatic environment (Higaki et al., 1992; Regan, 1993; Berg and Shi, 1996). It is likely that at least two histidines form the high affinity Zn2+ binding site in the alpha 1beta 1 GABAA receptor. The subunit stoichiometry of the alpha 1beta 1 GABAA receptor is uncertain, and evidence has been reported for both two alpha  and three beta  subunits (Tretter et al., 1997) and three alpha  and two beta  subunits (Im et al., 1995; Kellenberger et al., 1996; Gorrie et al., 1997). We are uncertain why the affinity for Zn2+ is 50-fold higher when the histidine is in the beta  subunit in wild-type receptor compared with when the histidine is in the alpha  subunit in the alpha 1S272Hbeta 1H267S mutant (Table 2). There are several potential explanations for this difference in affinity. If the subunit stoichiometry is 2alpha :3beta , then the high affinity site could be formed between histidines in the adjacent beta  subunits that would be present (Fig. 6A); alternatively, all three histidines might interact with the Zn2+ (Fig. 6A). The lower affinity observed when the histidine was in the alpha  subunit would arise because there would be two histidines in nonadjacent subunits that might be less favorable for Zn2+ binding (Fig. 6B). Alternatively, neighboring channel-lining residues, such as beta 1Glu270, also might influence the interaction between the histidines and Zn2+, thereby resulting in a higher affinity interaction when the histidine is in the beta  subunit compared with the alpha  subunit, where the adjacent channel-lining residue is alpha 1Asn275. Finally, the position of the alpha  and beta  subunits relative to the channel may not be symmetrical, and the difference in the affinity is due to the asymmetry and not to the relative number of subunits.


View larger version (15K):
[in this window]
[in a new window]
 
Fig. 6.   Position of subunits and the histidine residues in the wild-type alpha 1beta 1 receptor and in the alpha 1S272Hbeta 1H267S double mutant relative to the channel and the bound Zn2+ ion. A, Top view of the channel formed by two alpha 1 and three beta 1 subunits. B, Top view of the channel formed by two alpha 1S272H and three beta 1H267S subunits.

In X-ray crystal structures of proteins containing Zn2+ bound through histidine residues, the separation between the Zn2+ and the epsilon -amino group is ~2 Å (Higaki et al., 1992). This distance and the size of histidine constrain the maximum separation of the alpha  carbons of two histidine residues bound to a Zn2+ ion to <13 Å (Higaki et al., 1992). Thus, in the Zn2+ bound state of the GABAA receptor, at the level of beta 1His267, the alpha  carbons of the aligned residues in both adjacent and nonadjacent subunits must be <13 Å apart (Fig. 7B, distances A-B and A-C).


View larger version (32K):
[in this window]
[in a new window]
 
Fig. 7.   Two views of the M2 membrane-spanning segments of the GABAA receptor, the positions of the Zn2+ and picrotoxin binding sites, and the inferred distances between subunits and within the channel. A, Channel-lining residues in the M2 segments of the alpha 1 and beta 1 subunits. The channel-lining residues (black-square) in the alpha 1 subunit were identified by the substituted-cysteine-accessibility method (Xu and Akabas, 1996). square , Aligned residues in the beta 1 subunit. PTX, inferred location of the picrotoxin binding site (Xu et al., 1995). Zn2+, location of the Zn2+ binding site determined in this report. B, Three-dimensional representation of the M2 segments lining the GABAA receptor channel. Three of the five M2 segments are shown; the front two have been removed. Top, extracellular end. The M2 segments are shown as kinked helices based on their inferred structure from the 9-Å resolution structure of the homologous ACh receptor (Unwin, 1993). Points A-C, level of beta 1His267, the Zn2+ binding site. AB, distance between adjacent subunits. AC, distance between nonadjacent subunits. The distances between the Calpha carbons of the residues at these positions must be <13 Å. Points D and E, at the level of alpha 1Val257, the picrotoxin binding site (Xu et al., 1995). DE, must be >= 9 Å, the diameter of picrotoxin. Points F and G, at the narrowest region of the channel, the functional diameter of which was inferred to be ~5.6 Å based on the size of the largest permeant anion (Bormann et al., 1987).

Our previous work demonstrated that picrotoxin, a rigid, roughly spherical molecule 9 Å in diameter, binds near the cytoplasmic end of the channel in the region of alpha 1Val257 (Fig. 7, distance D-E) (Xu et al., 1995). Because it reaches that site from the extracellular end of the channel, we inferred that the channel lumen must be >= 9 Å in diameter to the level of alpha 1Val257 (Fig. 7) (Xu et al., 1995). Our current results constrain the maximum separation of the alpha  carbon atoms on nonadjacent subunits at the level of beta 1His267 to <13 Å. It should be noted, however, that these distances may be measured in different states of the receptor. Picrotoxin binds in the open state of the channel (Newland and Cull-Candy, 1992), and Zn2+ may bind in the closed state of the channel (Smart et al., 1994). We do know, however, that charged sulfhydryl reactive reagents can react with engineered cysteine residues in the alpha 1 M2 segment in the closed state of the channel (Xu and Akabas, 1996). These reagents would fit into a right cylinder 6 Å in diameter and 10 Å in length. Thus, in the closed state of the channel, the lumen must be >= 6 Å in diameter to allow these reagents to reach the engineered cysteine residues at positions more cytoplasmic than beta 1His267 (Xu and Akabas, 1996), but the alpha  carbons of the residues aligned with beta 1His267 must be closer than 13 Å. The narrowest region in the channel was inferred, based on the size of the largest permeant anion, to be ~5.6 Å (Bormann et al., 1987), but this must be at a position that is more cytoplasmic than the picrotoxin binding site (Fig. 7B, distance F-G).

If the channel were lined by five alpha  helical M2 segments arranged perpendicular to the membrane, the separation between the aligned position on the surface of adjacent alpha  helices would be ~4 Å and that between nonadjacent alpha -helices would be ~7 Å: The channel, however, is unlikely to be lined by five helices perpendicular to the membrane. In the 9 Å resolution structure of the ACh receptor reported by Unwin (1993), the putative M2 segments are not perpendicular to the membrane but rather angle out from the central channel axis toward the extracellular end of the channel (as illustrated in Fig. 7B). In the ACh receptor, we showed that residues near the extracellular end of the M1 membrane-spanning segment also were exposed in the channel lining, and we suggested that in the closed state, the M1 segments may intercalate between the M2 segments at the extracellular end of the channel (Akabas and Karlin, 1995). Thus, the 13 Å constraint on the separation of the alpha  carbons seems to be reasonable given our current structural picture of the channel.

The GABAA receptor forms a nearly ideally anion-selective channel (Bormann et al., 1987). The ability of a divalent cation, Zn2+, to penetrate from the extracellular end of the channel to the level of beta 1His267 in the M2 membrane-spanning segment indicates that the charge-selectivity filter that discriminates between anions and cations must be located at a more cytoplasmic position than beta 1His267. This is consistent with our previous results (Xu and Akabas, 1996) that showed that cationic sulfhydryl reagents could react with cysteines substituted for residues as cytoplasmic as alpha 1Thr261, which aligns with beta 1Thr256 (Fig. 7A). We inferred that the charge-selectivity filter is located at a more cytoplasmic position than these residues, perhaps near the cytoplasmic end of the channel where the channel seems to narrow and form a picrotoxin binding site (Xu et al., 1995).

As other investigators had shown (Draguhn et al., 1990; Smart et al., 1991), the presence of the gamma 2 subunit markedly reduces the affinity for Zn2+. The mechanism of this inhibition is not solely due to the lack of a histidine at the aligned position in the channel because substitution of a histidine at that position did not increase the affinity for Zn2+ (Table 2). Thus, some other aspect of the gamma 2 subunit prevents Zn2+ inhibition of GABA-induced currents. Potential explanations include that (1) the gamma 2 subunit may sterically restrict the conformations of the other subunits, and particularly beta 1His267, from adopting the conformation to which Zn2+ binds; (2) the putative adjacent channel-lining residue gamma 2Lys285 may electrostatically interfere with Zn2+ binding; and (3) Zn2+ might still bind to the receptor complex containing the gamma 2 subunit, but the presence of the gamma 2 subunit prevents the conformational change induced by Zn2+ in the alpha 1beta 1 receptor.

    Acknowledgments

We thank Drs. Peter Seeburg and Allan Tobin for the gifts of the GABAA receptor subunit cDNAs, David Liu and Dr. Steven Siegelbaum for the gift of the pGEMHE plasmid, Gilda Salazar-Jimenez for preparing X. laevis oocytes, and Drs. Jonathan Javitch, Arthur Karlin, Juan Pascual, Geoff Smith, and Gary Wilson for helpful discussions and comments on this manuscript.

    Footnotes

Received November 10, 1997; Accepted January 16, 1998

This work was supported in part by National Institutes of Health Grants NS30808 and DK51794. M.H.A. is the recipient of an Established Scientist Award from the American Heart Association, New York City Affiliate.

A preliminary report of this work has appeared in abstract form [Horenstein J and Akabas MH (1997) Soc Neurosci Abstr 23:112]. While preparing the manuscript, we were informed of a preliminary report describing similar results of mutation of the aligned residue in the beta 3 subunit, beta 3His292A [Wooltorton JRA, McDonald BJ, Moss SJ, and Smart TG (1997) Br J Pharmacol 122(suppl):38P]. A full version of this work was subsequently published in J Physiol (Lond) 505:633-640 (1997).

Send reprint requests to: Dr. Myles Akabas, Center for Molecular Recognition, Columbia University, 630 West 168th Street, Box 7, New York, NY 10032. E-mail: ma14{at}columbia.edu

    Abbreviations

GABAA, gamma -aminobutyric acid type A receptor; ACh, acetylcholine; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; CFFR, Ca2+-free frog Ringer's solution; GABA, gamma -aminobutyric acid; MTS, methanethiosulfonate; MTSES-, methanethiosulfonate ethylsulfonate; MTSET+, methanethiosulfonate ethyltrimethylammonium; pCMBS, p-chloromercuribenzenesulfonate.

    References
Top
Summary
Introduction
Materials & Methods
Results
Discussion
References


0026-895X/98/050870-08$3.00/0
MOLECULAR PHARMACOLOGY, 53:870-877 (1998).
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Neurophysiol.Home page
Z. Sun, D.-Q. Zhang, and D. G. McMahon
Zinc Modulation of Hemi-Gap-Junction Channel Currents in Retinal Horizontal Cells
J Neurophysiol, April 1, 2009; 101(4): 1774 - 1780.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Chen, K. A. Durkin, and J. E. Casida
Spontaneous Mobility of GABAA Receptor M2 Extracellular Half Relative to Noncompetitive Antagonist Action
J. Biol. Chem., December 15, 2006; 281(50): 38871 - 38878.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. Jansen and M. H. Akabas
State-dependent cross-linking of the M2 and M3 segments: functional basis for the alignment of GABAA and acetylcholine receptor M3 segments.
J. Neurosci., April 26, 2006; 26(17): 4492 - 4499.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
D. C. Reeves, M. Jansen, M. Bali, T. Lemster, and M. H. Akabas
A Role for the {beta}1-{beta}2 Loop in the Gating of 5-HT3 Receptors
J. Neurosci., October 12, 2005; 25(41): 9358 - 9366.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Bancila, T. Cens, D. Monnier, F. Chanson, C. Faure, Y. Dunant, and A. Bloc
Two SUR1-specific Histidine Residues Mandatory for Zinc-induced Activation of the Rat KATP Channel
J. Biol. Chem., March 11, 2005; 280(10): 8793 - 8799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Horenstein, P. Riegelhaupt, and M. H. Akabas
Differential Protein Mobility of the {gamma}-Aminobutyric Acid, Type A, Receptor {alpha} and {beta} Subunit Channel-lining Segments
J. Biol. Chem., January 14, 2005; 280(2): 1573 - 1581.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
X.-P. Chu, J. A. Wemmie, W.-Z. Wang, X.-M. Zhu, J. A. Saugstad, M. P. Price, R. P. Simon, and Z.-G. Xiong
Subunit-Dependent High-Affinity Zinc Inhibition of Acid-Sensing Ion Channels
J. Neurosci., October 6, 2004; 24(40): 8678 - 8689.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. N. Goren, D. C. Reeves, and M. H. Akabas
Loose Protein Packing around the Extracellular Half of the GABAA Receptor {beta}1 Subunit M2 Channel-lining Segment
J. Biol. Chem., March 19, 2004; 279(12): 11198 - 11205.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
H. Kim and R. L. Macdonald
An N-Terminal Histidine Is the Primary Determinant of {alpha} Subunit-Dependent Cu2+ Sensitivity of {alpha}{beta}3{gamma}2L GABAA Receptors
Mol. Pharmacol., November 1, 2003; 64(5): 1145 - 1152.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D D Wang, D D Krueger, and A Bordey
GABA Depolarizes Neuronal Progenitors of the Postnatal Subventricular Zone Via GABAA Receptor Activation
J. Physiol., August 1, 2003; 550(3): 785 - 800.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. T. Nevin, B. A. Cromer, J. L. Haddrill, C. J. Morton, M. W. Parker, and J. W. Lynch
Insights into the Structural Basis for Zinc Inhibition of the Glycine Receptor
J. Biol. Chem., August 1, 2003; 278(31): 28985 - 28992.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. K. Bera, M. Chatav, and M. H. Akabas
GABAA Receptor M2-M3 Loop Secondary Structure and Changes in Accessibility during Channel Gating
J. Biol. Chem., November 1, 2002; 277(45): 43002 - 43010.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
M. E. Wilkins, A. M. Hosie, and T. G. Smart
Identification of a beta Subunit TM2 Residue Mediating Proton Modulation of GABA Type A Receptors
J. Neurosci., July 1, 2002; 22(13): 5328 - 5333.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
T. J. Jentsch, V. Stein, F. Weinreich, and A. A. Zdebik
Molecular Structure and Physiological Function of Chloride Channels
Physiol Rev, April 1, 2002; 82(2): 503 - 568.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
N. Nagaya and R. L Macdonald
Two {gamma}2L subunit domains confer low Zn2+ sensitivity to ternary GABAA receptors
J. Physiol., April 1, 2001; 532(1): 17 - 30.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. Feigenspan, S. Gustincich, and E. Raviola
Pharmacology of GABAA Receptors of Retinal Dopaminergic Neurons
J Neurophysiol, October 1, 2000; 84(4): 1697 - 1707.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
B. Laube, J. Kuhse, and H. Betz
Kinetic and mutational analysis of Zn2+ modulation of recombinant human inhibitory glycine receptors
J. Physiol., January 15, 2000; 522(2): 215 - 230.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. J. Loland, L. Norregaard, and U. Gether
Defining Proximity Relationships in the Tertiary Structure of the Dopamine Transporter. IDENTIFICATION OF A CONSERVED GLUTAMIC ACID AS A THIRD COORDINATE IN THE ENDOGENOUS Zn2+-BINDING SITE
J. Biol. Chem., December 24, 1999; 274(52): 36928 - 36934.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
V. V. Koltchine, S. E. Finn, A. Jenkins, N. Nikolaeva, A. Lin, and N. L. Harrison
Agonist Gating and Isoflurane Potentiation in the Human gamma -Aminobutyric Acid Type A Receptor Determined by the Volume of a Second Transmembrane Domain Residue
Mol. Pharmacol., November 1, 1999; 56(5): 1087 - 1093.
[Abstract] [Full Text]


Home page
J. Physiol.Home page
R. J Harvey, P. Thomas, C. H James, A. Wilderspin, and T. G Smart
Identification of an inhibitory Zn2+ binding site on the human glycine receptor {alpha}1 subunit
J. Physiol., October 1, 1999; 520(1): 53 - 64.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
R.-Q. Huang and G. H. Dillon
Effect of Extracellular pH on GABA-Activated Current in Rat Recombinant Receptors and Thin Hypothalamic Slices
J Neurophysiol, September 1, 1999; 82(3): 1233 - 1243.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
X.-S. Wu, H. D. Edwards, and W. A. Sather
Side Chain Orientation in the Selectivity Filter of a Voltage-gated Ca2+ Channel
J. Biol. Chem., October 6, 2000; 275(41): 31778 - 31785.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. J. Boileau, J. G. Newell, and C. Czajkowski
GABAA Receptor beta 2 Tyr97 and Leu99 Line the GABA-binding Site. INSIGHTS INTO MECHANISMS OF AGONIST AND ANTAGONIST ACTIONS
J. Biol. Chem., January 18, 2002; 277(4): 2931 - 2937.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Horenstein, J.
Right arrow Articles by Akabas, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Horenstein, J.
Right arrow Articles by Akabas, M. H.


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics